Epidemiology and prevention of venous thromboembolism
Venous thromboembolism, that consists of the interrelated conditions deep-vein thrombosis
and pulmonary embolism, is an under-appreciated vascular disease. In Western regions …
and pulmonary embolism, is an under-appreciated vascular disease. In Western regions …
The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications
JD McFadyen, H Stevens, K Peter - Circulation research, 2020 - Am Heart Assoc
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …
and the ensuing global pandemic has presented a health emergency of unprecedented …
COVID-19 and its implications for thrombosis and anticoagulation
JM Connors, JH Levy - Blood, The Journal of the American …, 2020 - ashpublications.org
Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …
induced infection can be associated with a coagulopathy, findings consistent with infection …
[HTML][HTML] Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
N Tang, H Bai, X Chen, J Gong, D Li, Z Sun - Journal of thrombosis and …, 2020 - Elsevier
Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is
worrying, and the application of heparin in COVID‐19 has been recommended by some …
worrying, and the application of heparin in COVID‐19 has been recommended by some …
Thromboinflammation and the hypercoagulability of COVID‐19
JM Connors, JH Levy - Journal of thrombosis and haemostasis, 2020 - jthjournal.org
The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …
Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the …
JE Tamis-Holland, H Jneid, HR Reynolds, S Agewall… - Circulation, 2019 - Am Heart Assoc
Myocardial infarction in the absence of obstructive coronary artery disease is found in≈ 5%
to 6% of all patients with acute infarction who are referred for coronary angiography. There …
to 6% of all patients with acute infarction who are referred for coronary angiography. There …
The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease
East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …
Venous thrombosis
Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …
Environmental and genetic risk factors associated with venous thromboembolism
M Crous-Bou, LB Harrington… - Seminars in thrombosis …, 2016 - thieme-connect.com
Venous thromboembolism (VTE) includes deep vein thrombosis and pulmonary embolism,
and a combination of environmental and genetic risk factors contributes to VTE risk. Within …
and a combination of environmental and genetic risk factors contributes to VTE risk. Within …
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management
ABSTRACT Introduction SARS-CoV-2, the causative agent of COVID-19, attacks the
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …